[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ataibeckley Inc (ATAI)

Ataibeckley Inc (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,639,758
  • Shares Outstanding, K 368,167
  • Annual Sales, $ 4,090 K
  • Annual Income, $ -660,050 K
  • EBIT $ -54 M
  • EBITDA $ -102 M
  • 60-Month Beta 1.56
  • Price/Sales 646.48
  • Price/Cash Flow N/A
  • Price/Book 10.73

Options Overview Details

View History
  • Implied Volatility 14.08% (+0.67%)
  • Historical Volatility 110.87%
  • IV Percentile 1%
  • IV Rank 0.47%
  • IV High 155.11% on 11/10/25
  • IV Low 13.41% on 07/22/26
  • Expected Move (DTE 28) 0.20 (2.73%)
  • Put/Call Vol Ratio 0.29
  • Today's Volume 1,552
  • Volume Avg (30-Day) 9,516
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 99,675
  • Open Int (30-Day) 92,265
  • Expected Range 6.97 to 7.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.10
  • Number of Estimates 3
  • High Estimate $-0.09
  • Low Estimate $-0.10
  • Prior Year $-0.14
  • Growth Rate Est. (year over year) +28.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.08 +75.74%
on 06/24/26
7.22 -0.69%
on 07/17/26
+3.07 (+74.88%)
since 06/23/26
3-Month
3.67 +95.36%
on 06/11/26
7.22 -0.69%
on 07/17/26
+2.40 (+50.31%)
since 04/23/26
52-Week
3.06 +134.31%
on 07/28/25
7.22 -0.69%
on 07/17/26
+3.29 (+84.79%)
since 07/23/25

Most Recent Stories

More News
Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

PSNL : 12.22 (-2.00%)
ATAI : 7.17 (-0.14%)
LXP : 60.82 (-0.54%)
DSGR : 34.50 (-0.03%)
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates

EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END

HELP : 7.73 (-1.15%)
CMPS : 11.71 (-1.84%)
ATAI : 7.17 (-0.14%)
JNJ : 259.27 (+1.42%)
LLY : 1,185.87 (+1.97%)
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of AtaiBeckley ...

ATAI : 7.17 (-0.14%)
LLY : 1,185.87 (+1.97%)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of AtaiBeckley Inc. (NASDAQ: ATAI)

NEW YORK , July 16, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

ATAI : 7.17 (-0.14%)
Eli Lilly Is Buying AtaiBeckley in $2.8 Billion Deal. What It Means for LLY Stock

Eli Lilly stock rallies on a $2.8 billion acquisition of AtaiBeckley. Here’s why the deal is bullish for LLY shares.

ATAI : 7.17 (-0.14%)
JNJ : 259.27 (+1.42%)
LLY : 1,185.87 (+1.97%)
Shareholder Alert: Ademi LLP investigates whether AtaiBeckley Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE , July 16, 2026 /PRNewswire/ -- Ademi LLP is investigating AtaiBeckley (Nasdaq: ATAI) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction...

ATAI : 7.17 (-0.14%)
ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether AtaiBeckley Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior...

ATAI : 7.17 (-0.14%)
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

AtaiBeckley's lead program, BPL-003, is designed to provide durable relief from treatment-resistant depression

ATAI : 7.17 (-0.14%)
LLY : 1,185.87 (+1.97%)
AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder

156 patients randomized in multi-center, double-blind, placebo-controlled Phase 2b Elumina trial; topline data anticipated in Q4 2026 (ClinicalTrials.gov:  NCT06524830 ) AtaiBeckley plans to advance...

ATAI : 7.17 (-0.14%)
AtaiBeckley to Join the Russell Indexes, Expanding Visibility Across U.S. Equity Markets

AtaiBeckley to be added to the Russell 2000® Index and the broad-market Russell 3000® Index as part of 2026 reconstitution The Russell U.S. Indexes have approximately $12.2 trillion in assets benchmarked...

ATAI : 7.17 (-0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

AtaiBeckley Inc. is a clinical-stage biopharmaceutical company developing mental health treatments. The company's pipeline of novel therapies includes BPL-003 for treatment-resistant depression, VLS-01 for TRD and EMP-01 for social anxiety disorder. AtaiBeckley Inc., formerly known as Atai Beckley...

See More

Key Turning Points

3rd Resistance Point 7.25
2nd Resistance Point 7.22
1st Resistance Point 7.20
Last Price 7.17
1st Support Level 7.15
2nd Support Level 7.12
3rd Support Level 7.10

See More

52-Week High 7.22
Last Price 7.17
Fibonacci 61.8% 5.63
Fibonacci 50% 5.14
Fibonacci 38.2% 4.65
52-Week Low 3.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.